These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22476844)

  • 1. Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis.
    Borgen PO; Dahl OE; Reikerås O
    Clin Orthop Relat Res; 2012 Sep; 470(9):2591-8. PubMed ID: 22476844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative versus postoperative initiation of dalteparin thromboprophylaxis in THA.
    Borgen PO; Dahl OE; Reikeras O
    Hip Int; 2010; 20(3):301-7. PubMed ID: 20640994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Charoencholvanich K; Siriwattanasakul P
    Clin Orthop Relat Res; 2011 Oct; 469(10):2874-80. PubMed ID: 21512813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study.
    Borgen PO; Pripp AH; Dybvik E; Leistad L; Dahl OE; Reikerås O
    Clin Orthop Relat Res; 2017 Sep; 475(9):2245-2252. PubMed ID: 28643079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study.
    Levy O; Martinowitz U; Oran A; Tauber C; Horoszowski H
    J Bone Joint Surg Am; 1999 Nov; 81(11):1580-8. PubMed ID: 10565650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2199-207. PubMed ID: 10904464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined administration of dextran 70 and dalteparin does not increase perioperative blood loss compared to dextran 70 alone in major orthopedic surgery.
    Dahl OE; Walsoe HK; Aspelin T; Roise O; Arnesen H; Lyberg T
    Haemostasis; 1999; 29(5):262-8. PubMed ID: 10754378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
    Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
    Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
    Gombár C; Gálity H; Bácsi M; Sisák K
    Orv Hetil; 2019 Mar; 160(12):456-463. PubMed ID: 30876382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Surgical Approach Affect Patient-reported Function After Primary THA?
    Graves SC; Dropkin BM; Keeney BJ; Lurie JD; Tomek IM
    Clin Orthop Relat Res; 2016 Apr; 474(4):971-81. PubMed ID: 26620966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
    Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
    Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty.
    Yamasaki S; Masuhara K; Fuji T
    J Bone Joint Surg Am; 2005 Apr; 87(4):766-70. PubMed ID: 15805205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
    Clavé A; Fazilleau F; Dumser D; Lacroix J
    Orthop Traumatol Surg Res; 2012 Sep; 98(5):484-90. PubMed ID: 22542983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.
    Lassen MR; Borris LC; Anderson BS; Jensen HP; Skejø Bro HP; Andersen G; Petersen AO; Siem P; Hørlyck E; Jensen BV; Thomsen PB; Hansen BR; Erin-Madsen J; Møller JC; Rotwitt L; Christensen F; Nielsen JB; Jørgensen PS; Paaske B; Tørholm C; Hvidt P; Jensen NK; Nielsen AB; Appelquist E; Tjalve E
    Thromb Res; 1998 Mar; 89(6):281-7. PubMed ID: 9669750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty?
    Zhang Y; Zhang L; Ma X; Jia Y; Wang H; Zhu Y; Liu Y
    Orthopade; 2016 Jul; 45(7):616-21. PubMed ID: 27142970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.